Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-16 6:33 pm Sale | 2024-12-03 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 616,502 8.450% | -8,953 (-1.43%) | Filing History |
| 2023-10-04 4:19 pm Sale | 2023-09-25 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 2,313,227 3.430% | -2,305,619 (-49.92%) | Filing History |
| 2023-09-19 9:30 pm Purchase | 2023-09-11 | 13G | NewAmsterdam Pharma Company N.V. NAMS | Morningside Venture Investments Limited | 4,060,923 4.930% | 4,060,923 (New Position) | Filing History |
| 2023-08-17 5:15 pm Sale | 2023-08-15 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 4,618,846 6.860% | -4,000,000 (-46.41%) | Filing History |
| 2023-08-17 5:14 pm Unchanged | 2023-08-15 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 625,455 8.600% | 0 (Unchanged) | Filing History |
| 2023-07-25 4:01 pm Sale | 2023-07-24 | 13D | GreenLight Biosciences Holdings GRNA | Morningside Venture Investments Limited | 0 0.000% | -16,919,155 (Position Closed) | Filing History |
| 2023-06-07 5:28 pm Purchase | 2023-05-29 | 13D | GreenLight Biosciences Holdings GRNA | Morningside Venture Investments Limited | 16,919,155 11.150% | 3,061,224 (+22.09%) | Filing History |
| 2023-04-03 4:43 pm Sale | 2023-03-29 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 8,618,846 12.920% | -683,296 (-7.35%) | Filing History |
| 2023-02-23 4:17 pm Unchanged | 2022-07-21 | 13D | LUMIRADX LTD SHS LTD LMDXF | Morningside Venture Investments Limited | 54,127,838 30.200% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:04 pm Purchase | 2022-03-28 | 13D | LUMIRADX LTD SHS LTD LMDXF | Morningside Venture Investments Limited | 54,127,838 30.200% | 34,632,690 (+177.65%) | Filing History |
| 2022-12-02 4:05 pm Purchase | 2022-11-22 | 13G | Frazier Lifesciences Acquisition Corporation FLAC | Morningside Venture Investments Limited | 5,065,846 6.210% | 5,065,846 (New Position) | Filing History |
| 2022-09-30 4:05 pm Sale | 2022-09-23 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 9,302,142 15.890% | -1,376,666 (-12.89%) | Filing History |
| 2022-02-16 4:00 pm Sale | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Morningside Venture Investments Limited | 0 0.000% | -6,634,956 (Position Closed) | Filing History |
| 2022-02-14 4:18 pm Purchase | 2021-12-31 | 13G | LUMIRADX LTD SHS LTD LMDXF | Morningside Venture Investments Limited | 19,495,148 40.900% | 19,495,148 (New Position) | Filing History |
| 2022-02-14 4:07 pm Purchase | 2022-02-02 | 13D | GreenLight Biosciences Holdings GRNA | Morningside Venture Investments Limited | 13,857,931 11.300% | 13,857,931 (New Position) | Filing History |
| 2022-02-14 4:05 pm Purchase | 2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | Morningside Venture Investments Limited | 12,806,342 13.200% | 250,000 (+1.99%) | Filing History |
| 2022-01-25 4:54 pm Purchase | 2022-01-11 | 13D | Amylyx Pharmaceuticals, Inc. AMLX | Morningside Venture Investments Limited | 10,678,808 18.900% | 10,678,808 (New Position) | Filing History |
| 2021-11-22 07:51 am Purchase | 2021-02-26 | 13D | Stealth BioTherapeutics Corp MITO | Morningside Venture Investments Limited | 540,133,192 66.500% | 540,133,192 (New Position) | Filing History |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Morningside Venture Investments Limited | 6,634,956 8.030% | 6,634,956 (New Position) | Filing History |
| 2021-02-16 4:17 pm Purchase | 2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | Morningside Venture Investments Limited | 12,556,342 15.800% | 540,540 (+4.50%) | Filing History |